{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:39:32Z","timestamp":1792888772170,"version":"4.5.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260343-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Blood-based neural biomarkers linked to aging may provide insights into the biological end point of the human lifespan. However, the key biomarker associated with cognition and mortality in centenarians remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the associations between 3 neural biomarkers\u2014amyloid-\u03b242 and amyloid-\u03b240 ratio (A\u03b242\/40), phosphorylated tau 181 (p-tau181), and neurofilament light chain (NfL)\u2014and both cognitive function and all-cause mortality in centenarians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based cohort study included Japanese centenarians aged 100 years or older who were enrolled between September 2000 and January 2021. Participants underwent baseline cognitive assessments and blood sampling and were followed up for 17 years for mortality. Data analysis was performed in February 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Baseline plasma levels of A\u03b242\/40, p-tau181, and NfL measured using ultrasensitive immunoassays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Cognitive function at baseline, measured using the Mini-Mental State Examination (MMSE), and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 495 participants (398 [80.4%] women; mean [SD] age 104.1 [3.0] years), 419 completed a cognitive assessment (mean [SD] MMSE, 14.9 [6.9]). During 17 years of follow-up, 466 participants (95.5%) died. Lower A\u03b242\/40 (\u03b2\u2009=\u20090.99; 95% CI, 0.46 to 1.52) and higher NfL levels (\u03b2\u2009=\u2009\u22120.92; 95% CI, \u22121.62 to \u22120.23) were significantly associated with lower MMSE scores after adjusting for confounders. Higher NfL levels were also associated with increased mortality (hazard ratio, 1.36; 95% CI, 1.17 to 1.57), showing the greatest point estimate among the biomarkers, all of which were standardized and statistically significant (change in Akaike Information Criterion, likelihood ratio test, \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200930.16;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). A\u03b242\/40 and p-tau181 were not statistically significant after full adjustment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260343-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of centenarians, higher plasma NfL levels were associated with lower cognitive function and increased all-cause mortality, whereas A\u03b242\/40 and p-tau181 showed  no associations. These findings suggest that plasma NfL was associated with neurodegeneration in extreme aging. Further studies are needed to confirm its clinical utility before routine implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.11335","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:30:26Z","timestamp":1778167826000},"page":"e2611335","source":"Crossref","is-referenced-by-count":3,"title":["Biomarkers, Cognitive Function, and Mortality in Centenarians"],"prefix":"10.1001","volume":"9","author":[{"given":"Ryo","family":"Shikimoto","sequence":"first","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"},{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"},{"name":"Health\/Consultation Comprehensive Support Organization, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Abe","sequence":"additional","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tai","sequence":"additional","affiliation":[{"name":"Eisai-Keio Innovation Laboratory for Dementia, Neurology Discovery, DHBL, Eisai Co, Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Hirose","sequence":"additional","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"},{"name":"Keio University Regenerative Medicine Research Center, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumichi","family":"Arai","sequence":"additional","affiliation":[{"name":"Center for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan"},{"name":"Faculty of Nursing and Medical care, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"7","key":"zoi260343r1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaneurol.2023.1331","article-title":"Association between acute myocardial infarction and cognition.","volume":"80","author":"Johansen","year":"2023","journal-title":"JAMA Neurol"},{"key":"zoi260343r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101762","article-title":"Association of kidney function and brain health: a systematic review and meta-analysis of cohort studies.","volume":"82","author":"Tang","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"1","key":"zoi260343r3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41398-020-01018-7","article-title":"Immune response and endocytosis pathways are associated with the resilience against Alzheimer\u2019s disease.","volume":"10","author":"Tesi","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"10","key":"zoi260343r4","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s43587-024-00716-x","article-title":"The brain-body energy conservation model of aging.","volume":"4","author":"Shaulson","year":"2024","journal-title":"Nat Aging"},{"issue":"6","key":"zoi260343r5","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging.","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"8","key":"zoi260343r6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","article-title":"Autophagy in healthy aging and disease.","volume":"1","author":"Aman","year":"2021","journal-title":"Nat Aging"},{"issue":"6","key":"zoi260343r7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial.","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"zoi260343r8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease.","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi260343r9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/jnen\/nlw033","article-title":"\u201cNew old pathologies\u201d: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS).","volume":"75","author":"Nelson","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"zoi260343r10","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1002\/alz.13087","article-title":"The correlation between neuropathology levels and cognitive performance in centenarians.","volume":"19","author":"Zhang","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi260343r11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biom14010093","article-title":"Blood biomarkers of Alzheimer\u2019s disease and cognition: a literature review.","volume":"14","author":"Garcia-Escobar","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"zoi260343r12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"zoi260343r13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers.","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"issue":"5","key":"zoi260343r14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"issue":"9","key":"zoi260343r15","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1212\/WNL.0000000000013229","article-title":"Association of serum neurofilament light chain concentration and MRI findings in older adults: the cardiovascular health study.","volume":"98","author":"Fohner","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"zoi260343r16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3233\/JAD-215639","article-title":"Blood phosphorylated tau 181 as a biomarker for amyloid burden on brain PET in cognitively healthy adults.","volume":"87","author":"McGrath","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"zoi260343r17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jamaneurol.2018.3459","article-title":"Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment.","volume":"76","author":"Kern","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"zoi260343r18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000017035","article-title":"Increased plasma concentration of serum amyloid P component in centenarians with impaired cognitive performance.","volume":"9","author":"Nybo","year":"1998","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"zoi260343r19","doi-asserted-by":"publisher","first-page":"M357","DOI":"10.1093\/gerona\/54.7.M357","article-title":"A high plasma concentration of TNF-alpha is associated with dementia in centenarians.","volume":"54","author":"Bruunsgaard","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"zoi260343r20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70155","article-title":"Distinct patterns of cognitive traits in extreme old age and Alzheimer\u2019s disease.","volume":"21","author":"Nishimoto","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi260343r21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-023-01220-x","article-title":"Association between ATN profiles and mortality in a clinical cohort of patients with cognitive disorders.","volume":"15","author":"R\u00e9gy","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"zoi260343r22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jgs.18632","article-title":"Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.","volume":"72","author":"Halloway","year":"2024","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi260343r23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12916-021-01915-8","article-title":"Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study.","volume":"19","author":"R\u00fcbsamen","year":"2021","journal-title":"BMC Med"},{"issue":"10","key":"zoi260343r24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/gerona\/glu003","article-title":"Cognitive performance and functional status are the major factors predicting survival of centenarians in Poland.","volume":"69","author":"Mossakowska","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"zoi260343r25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11357-015-9822-9","article-title":"Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians.","volume":"37","author":"Szewieczek","year":"2015","journal-title":"Age (Dordr)"},{"issue":"1","key":"zoi260343r26","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/s41467-020-17636-0","article-title":"Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages.","volume":"11","author":"Hirata","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"zoi260343r27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s43587-021-00028-4","article-title":"A neuronal blood marker is associated with mortality in old age.","volume":"1","author":"Kaeser","year":"2021","journal-title":"Nat Aging"},{"issue":"3","key":"zoi260343r28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/gerona\/61.3.305","article-title":"Functional status of centenarians in Tokyo, Japan: developing better phenotypes of exceptional longevity.","volume":"61","author":"Gondo","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"zoi260343r29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2318-10-35","article-title":"The Tokyo Oldest Old survey on Total Health (TOOTH): a longitudinal cohort study of multidimensional components of health and well-being.","volume":"10","author":"Arai","year":"2010","journal-title":"BMC Geriatr"},{"issue":"4","key":"zoi260343r30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/gerona\/glt146","article-title":"Physical independence and mortality at the extreme limit of life span: supercentenarians study in Japan.","volume":"69","author":"Arai","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"zoi260343r31","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ebiom.2015.07.029","article-title":"Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians.","volume":"2","author":"Arai","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"zoi260343r32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease.","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"zoi260343r33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-\u00df levels and risk of dementia; a population-based cohort study.","volume":"143","author":"de Wolf","year":"2020","journal-title":"Brain"},{"issue":"1","key":"zoi260343r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.31654","article-title":"Association of cognitive function trajectories in centenarians with postmortem neuropathology, physical health, and other risk factors for cognitive decline.","volume":"4","author":"Beker","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi260343r35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/archneurol.2011.1841","article-title":"Plasma amyloid-\u00df as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.","volume":"69","author":"Koyama","year":"2012","journal-title":"Arch Neurol"},{"issue":"8","key":"zoi260343r36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"zoi260343r37","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-200475","article-title":"Plasma amyloid-\u00df biomarker associated with cognitive decline in preclinical Alzheimer\u2019s disease.","volume":"77","author":"Lim","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"zoi260343r38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-230799","article-title":"The associations of phosphorylated tau 181 and tau 231 levels in plasma and cerebrospinal fluid with cognitive function in Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"98","author":"Li","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"7691","key":"zoi260343r39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u00df biomarkers for Alzheimer\u2019s disease.","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"8","key":"zoi260343r40","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/cells12081184","article-title":"Utility of blood-based tau biomarkers for mild cognitive impairment and Alzheimer\u2019s disease: systematic review and meta-analysis.","volume":"12","author":"Zabala-Findlay","year":"2023","journal-title":"Cells"},{"key":"zoi260343r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101446","article-title":"Diagnostic accuracy of blood biomarkers for Alzheimer\u2019s disease and amnestic mild cognitive impairment: a meta-analysis.","volume":"71","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"2","key":"zoi260343r42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/0361073X.2013.761869","article-title":"Profiles of cognitive functioning in a population-based sample of centenarians using factor mixture analysis.","volume":"39","author":"Davey","year":"2013","journal-title":"Exp Aging Res"},{"issue":"3","key":"zoi260343r43","doi-asserted-by":"publisher","DOI":"10.20900\/agmr20200018","article-title":"Centenarians as models of resistance and resilience to Alzheimer\u2019s disease and related dementias.","volume":"2","author":"Andersen","year":"2020","journal-title":"Adv Geriatr Med Res"},{"issue":"1","key":"zoi260343r44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12916-022-02425-x","article-title":"Plasma neurofilament light and its association with all-cause mortality risk among urban middle-aged men and women.","volume":"20","author":"Beydoun","year":"2022","journal-title":"BMC Med"},{"issue":"8","key":"zoi260343r45","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls.","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"4","key":"zoi260343r46","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00415-023-12153-8","article-title":"Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort.","volume":"271","author":"Sarto","year":"2024","journal-title":"J Neurol"},{"issue":"5","key":"zoi260343r47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"issue":"3","key":"zoi260343r48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"zoi260343r49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848754\/shikimoto_2026_oi_260343_1777584074.30216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:30:27Z","timestamp":1778167827000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.11335","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}